Update on COVID-19 Vaccinations for 2024-2025 Season

Centers for Medicare and Medicaid Services (CMS) issued the following Medicare billing guidance regarding the FDA-approved updated COVID-19 vaccines for the 2024–2025 season:  

• mRNA vaccines made by Pfizer-BioNTech and Moderna on August 22, 2024   

• Novavax COVID-19 Vaccine, Adjuvanted on August 30, 20

These vaccines target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization and death:  

• The Pfizer-BioNTech and Moderna COVID-19 vaccines include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2.  

• The Novavax COVID-19 Vaccine, Adjuvanted, includes a monovalent (single) component that corresponds to the Omicron variant JN.1 strain of SARS-CoV-2.  

CMS has updated COVID-19 vaccine pricing for the 2024–2025 season:

• CPT codes 91318–91322, effective August 22, 2024 (Note: no change to payment allowances from last season for 91318–91319)  

• CPT code 91304, effective August 30, 2024  

Use CPT code 90480 to bill for the administration of the vaccine.  

Visit the COVID-19 Vaccine Provider Toolkit for more information.